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Commonly Used Abbreviations 
 
 
FGF-2                                        Basic Fibroblast Growth Factor 
 
VEGF                               Vascular Endothelial Growth Factor 
 
PDGF                                        Platelet Derived Growth Factor 
 
PIGF                                          Placenta Derived Growth Factor 
 
TGF                                           Transforming Growth Factor 
 
TNF-α                                       Tumor Necrosis Factor-Alpha 
 
TNF-β                                       Tumor Necrosis Factor-Beta 
 
GF                                             Growth Factor 
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PCR                                           Polymerase Chain Reaction 
 
RT                                             Reverse Transcriptase 
 
RNA                                          Ribonucleic Acid  
 
DNA                                          Deoxyribonucleic Acid 
 
DMEM                                      Dulbecco’s Modified Eagle Medium 
 
ELISA                                       Enzyme-Linked Immunosorbent Assay 
 
Ab                                             Antibody 
   
   
 
EC                                             Endothelial Cell 
 
SD                                             Shallow Decay 
 
DD                                            Deep Decay 
 
C                                               Control  
 
PBS                                           Phosphate Buffered Solution 
 
ETOH                                        Ethanol 
 
Hrs                                             Hours 
 
Min                                            Minutes 
 
Sec                                             Seconds 
 
Ref.                                            Reference No. 
 
#                                                 Number 
 
IRB                                            Institutional Review Board 
 
NA                                             Neutralizing Antibody 
 
HDPF                                         Human Dental Pulp Fibroblasts 
 





   





Table 1. Sample distribution in the shallow decay group by age, sex, tooth 
type. Optical density and FGF-2 protein concentration in pg/ml measured by 
ELISA.  
 
Table 2. Sample distribution in the deep decay group by sex, age, and tooth 
type. Optical density and FGF-2 protein concentration in pg/ml measured by 
ELISA. 
 
Table 3. Table showing mRNA concentration from control and decayed 



























   
   
 
FIGURE LEGENDS 
Figure 1. A sectioned tooth with the 'Shallow Decay' showing sound dentin 
separating the carious lesion from the pulp chamber. 
 
Figure 2. A tooth sectioned with 'Deep Decay' showing the carious lesion in 
contact with the pulp. 
 
Figure 3. Diamond Wheel Saw Model 650 (Southbay Technologies, San 
Clemente, California) with a tooth glued to a wooden mounting in the 
cutting jig. Sectioning was carried out in a fume chemical hood under 
aseptic conditions. 
 
Figure 4. A caries free tooth longitudinally prior to removing the pulp. .  
Figure 5. FGF-2 protein expression showing the general trend and range of 
expression for the shallow decay group. (P<0.942) (t-test). 
 
Figure 6. Depicting percentage of samples showing FGF-2 expression up-
regulated in 9 of 15 samples (60%) and down-regulated in 6 of 15 samples 
(40%). 
 
Figure 7. Samples within shallow decay group showing up-regulation of 
FGF-2 protein expression. A statistical significant difference was present 
between each control and decayed sample (P<000.6) (t-test).  
 
Figure 8. Samples within shallow decay group showing down-regulation of FGF-2 
protein expression. A statistical significant difference was present between each 
control and decayed sample (P<0.0035) (t-test).  
 
Figure 9. FGF-2 protein expression levels showing the general trend and 
range of expression for the deep decay group. (P<0.642) (t-test). 
 
Figure 10. Depicting percentage of sample showing FGF-2 expression being 
up-regulated in 7 of 15 samples (46%) and down-regulated in 8 of 15 (54%). 
 
   
   
Figure 11. Samples within deep decay group showing up-regulation of FGF-2 
protein expression. A statistical significant difference was present between each 
control and decayed sample (P<0.0039) (t-test).  
 
Figure 12. Samples within deep decay group showing down-regulation of FGF-2 
protein expression. A statistical significant difference was present between each 
control and decayed sample (P<0.0041) (t-test).  
 
Figure 13. Selected samples from shallow decay (SD) (sample #10, A), and 
deep decay groups (DD) (sample #12, B) showing up-regulated FGF-2 
mRNA and protein expression. mRNA FGF-2 expression as analyzed by 
RT-PCR. GAPDH was run as house keeping gene and Human dental pulp 
fibroblasts (HDPF) as controls. FGF-2 protein expression as analyzed by 
ELISA 
 
.Figure 14. FGF-2 expression in the shallow decay group showing up-
regulation and down-regulation in the control vs the shallow decay group. 
The optical density of each amplified band was calculated using the Image J 
software Program (1.32 j) and then numerically expressed as the relative 
density and normalized to the house keeping gene (GAPDH). 
 
Figure 15. FGF-2 expression in the deep decay group showing up-regulation 
and down-regulation in the non-decay vs the deep decay teeth. The optical 
density of each amplified band was calculated using the Image J software 
Program (1.32 j) and then numerically expressed as the relative density and 
normalized to the house keeping gene (GAPDH).  
 
Figure 16. Graph representing the relative expression by means of Real-
Time PCR. Quantitative Real time mRNA FGF-2 expression did not show a 
statistically significant difference when comparing the non-carious group 









   






Fibroblast growth factor (FGF-2) plays a significant role in wound healing 
and increases local angiogenesis. Increased blood vessel permeability and 
angiogenesis are commonly found in caries-induced pulpitis. To date, there 
are no studies evaluating the presence of FGF-2 in pulp tissues from carious 
teeth. The purpose of this study is to evaluate the presence of FGF-2 in the 
pulp of carious teeth as compared to non-carious teeth. Thirty healthy 
patients (18-55 y/o) scheduled for multiple extractions were selected. One 
sound tooth and one carious vital tooth were collected from each patient. 
Teeth were grouped as deep caries (15) and shallow caries (15). Teeth were 
split, the pulp tissue removed and cut in half longitudinally. Protein and 
RNA were extracted and FGF-2 expression measured by ELISA, Reverse 
transcriptase polymerase chain reaction (RT-PCR) and Real-Time PCR. 
Either One-way analysis of variance (ANOVA) or the student t-test were 
used for statistical analysis. The analysis of protein expression evaluated by 
ELISA showed no statistical significant difference when comparing FGF-2 
expression in all shallow or deep decayed samples to non-decayed samples. 
Densitometric analysis of RT-PCR showed similar trends of increase or 
   
   
decrease of FGF-2 expression as analyzed by ELISA in 10 of 15 (67%) in 
the shallow decay group and 8 of 15 (54%) in the deep decay group. 
Quantitative analysis measured by Real Time PCR did not show a 
statistically significant difference when comparing FGF-2 expression in the 
non-carious versus the carious group. Age, sex and tooth type did not appear 
to be determinant factors in the up-regulation or down-regulation of FGF-2 
within the shallow decay or deep decay group. The results of this study 
revealed that human pulp tissue contains fibroblast growth factors (FGF-2) 
both in health and during inflammation. These findings provide an insight 
for understanding the role of FGF-2 in the mechanism of caries progression 
and inflammation. The results of this study revealed that human pulp tissue 
contains fibroblast growth factor (FGF-2) both in health and during 
inflammation. These findings provide an insight for understanding the role 
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1. Background and Significance 
Growth factors are diffusible cell-signaling molecules that pass between the 
epithelial and mesenchymal compartments of the tooth germ and are 
responsible for interactions during tooth development. These interactions 
determine the early morphogenic events in tooth development (Cobourne et 
al., 2003) as well as the later processes that give rise to odontoblasts (Ruch 
et al., 1995) and ameloblast differentiation (Unda F et al., 2001). 
The importance of growth factors in mediating the cellular response to injury 
in the dentin-pulp complex is well recognized. Several growth factors are 
reportedly sequestered in the dentin matrix from where they may be released 
during the repair process (Smith, 2002). The process of reactionary and 
reparative dentinogenesis at sites of dental injury are responsible for 
secretion of tertiary dentin matrices, which either increase the dentin barrier 
between the site of injury and the underlying cells in the unexposed pulp or 
provide a dentin bridge across the exposed pulp (Smith et al., 2002). Growth 
factors may be key molecules in the signaling of the biological events 
responsible for these repair processes (Smith et al., 2003). 
Vascular endothelial growth factor (VEGF), platelet derived growth factor 
(PDFG) and Fibroblast growth factor (FGF-2), are among the angiogenic 
growth factors identified in human dentin matrix and pulp tissue (Clark et 
   
  2 
al., 2000; Hung et al., 2007). Bacterial toxins such as lipoteichoic acid and 
lipopolysacharide increased the expression of angiogenic growth factors 
(VEGF) in odontoblast like cells (Telles et al., 20003; Botero et al., 2006). 
Hung et al., 2007 demonstrated how human pulp fibroblasts secrete VEGF, 
PDGF and FGF-2 after mechanical injury (Hung et al., 2007).  
The vitality of the dentin-pulp complex, both during tissue homeostasis and 
after injury is dependant on pulp cell activity and the signaling processes 
which regulate the behavior of these cells. Growth factors are peptide 
molecules that transmit signals between cells functioning as stimulators 
and/or inhibitors of growth as well as modulators of differentiation amongst 
other roles (Smith et al., 2003). The distribution of these growth factors 
between the organic and inorganic tissue compartments of the dentin matrix 
may reflect the manner in how they become sequestered within the tissue 
and will also determine their potential release characteristics (Clark et al., 
2000). The higher concentrations of most of these growth factors in the 
soluble compartments of dentin will allow ready release during dental caries 
(Clark et al., 2000).  
Diffusible angiogenic growth factors including (VEGF, FGF-2, PDGF, 
TGF-β) are regulated in the pulps of orthodontically moved teeth as 
compared with controls, where they might mediate local angiogenic 
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responses to tissue events (Derringer et al., 1998; Derringer et al., 1996). 
Derringer et al, 2004 showed by means of human dental pulp and rat aorta 
co-culture assay how these growth factors not only play a role in 
angiogenesis but at the same time function effectively when acting in 
combination (Derringer et al., 2004). Release of FGF-2 could account for 
the increased local angiogenesis observed at sites of dental tissue repair after 
dental caries (Baume et al., 1980; Schroder et al., 1985; Smith et al., 1990) 
or traumatic injury (Baume et al., 1980; Schroder et al., 1985; Smith et al., 
1990).  
The vascular responses that are observed in teeth with deep caries and the 
edema mediated by the potent angiogenic and vascular permeability factor 
VEGF may be detrimental to the dental pulp health (Botero et al., 2006). 
Thus, the overall response in the pulp is likely to be a summation of the 
effects arising from release of growth factors from the dentin matrix (Sloan 
and Smith, 1999) and more local secretion from the cells in the pulp itself 
(Sloan et al., 2000). 
The rationale for this investigation emerged from a review of the literature 
pertaining to the presence of fibroblast growth factor (FGF-2) during 
pulpitis. Currently there is no information of FGF-2 and its correlation with 
the progression of carious lesions into the pulp. It would be of value to 
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assess the presence of FGF-2 in the pulp. Additionally, the expression FGF-
2 should be evaluated in sound teeth and teeth with dental caries. The results 
of this study could provide relevant information to understand the 
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To demonstrate and measure the presence of FGF-2 in carious dental pulp as 





The pulps of teeth with carious lesions show higher levels of FGF-2 







The pulps of teeth with carious lesions do not show higher levels of FGF-2 
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Growth factors are naturally occurring biological mediators that act as 
signals between cells. They modulate cell growth and differentiation (Smith 
et al., 2003). As such they play a central role in controlling cell behavior and 
activity. Growth factors may demonstrate a degree of specificity in terms of 
the cells they act upon, although some are more versatile and act on 
numerous cell types. The dose dependency of their effects also varies, 
however, one of the characteristic features of these molecules is their 
potency at very low concentrations, typically in the picogram range (Smith 
et al., 2003). While many are named after the original source they were 
isolated from this may be misleading because a more widespread 
distribution has often been since demonstrated (Smith et al., 2003). 
Growth factors act through their interaction with specific receptors on the 
cell surface. Binding to these receptors leads to a chain of intracellular 
signals, the result of which is transmission of the signal to the cell nucleus 
(Matsuda et al., 1992; Graves and Cochran, 1994).  It is through their effects 
on gene expression in the cell nucleus, mediated by transcription and other 
factors, that growth factors influence cell behavior and activity. This 
transcriptional control of gene expression can have far-reaching effects both 
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in terms of intra- and extra-cellular events. Thus, growth factors may 
regulate genes controlling cell proliferation, cell differentiation, or the 
secretory products of the cell.  (Smith et al., 2003). 
Growth Factors in Tooth Development    
Growth factors are responsible for signaling many of the key events in tooth 
morphogenesis and differentiation (Cobourne et al., 2003) and 
recapitulation of these processes after dental injury allows tissue 
regeneration (Smith et al., 2002).  
During the late bell stage of tooth development, the inner dental epithelium 
and its associated basement membrane signal the peripheral cells of the 
dental papilla to differentiate into odontoblasts (Ruch et al., 1995). Growth 
factors, particularly of the transforming growth factor-β (TGF-β) family, 
appear to be important molecules mediating this signaling of odontoblast 
differentiation (Bègue et al., 1992). Secretion of these growth factors by the 
inner dental epithelium and their sequestration within the dental basement 
membrane for presentation to the dental papilla cells for signaling of 
odontoblast differentiation, provide the temporo-spatial control of these 
processes in the tooth germ (Ruch et al., 1995). However, in the mature 
tooth, similar processes must occur to allow differentiation of a new 
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generation of odontoblast-like cells for dentin bridge formation (Bègue et 
al., 1992). 
Growth Factors in the Dentin-Pulp Complex 
Dentin chips arising from operative debris have been known to be auto-
inductive for reparative dentinogenesis (Seltzer et al., 1990). 
Experimentally, demineralized dentin matrix and isolated dentin matrix 
components are also capable of inducing reparative dentinogenesis and 
bridge formation at sites of pulp exposure (Anneroth et al., 1972; 
Nakashima et al., 1989; Nakashima et al., 1990; Tziafas et al., 1990; Smith 
et al., 1990) as well as ectopic bone formation (Butler et al., 1977). This 
implies that dentin matrix contains bioactive components and is not as inert 
as sometimes presumed. The collagenous and non-collagenous proteins of 
dentin have been well reviewed (Linde et al., 1993; Butler et al., 1998; 
Butler et al., 2002), but the emphasis has been on the quantitatively more 
important components. It has now been possible to identify a number of 
growth factors in dentin matrix, which, while quantitatively minor 
components, may have potential biologic effects. The origin of these growth 
factors in dentin matrix is probably largely the odontoblast cell (Sloan et al., 
2000). Once incorporated within dentin matrix, these growth factors become 
“ fossilized ” and retain their biological activity through the protection 
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offered by their interaction with dentin extracellular matrix components 
(Sloan et al., 2000). 
Growth factors identified within human dentin matrix include VEGF, FGF-
2, TGF-β, PDGF, epidermal growth factor (EGF), insulin growth factor -1 
(IGF-1), insulin growth factor-2 (IGF-2) and placenta growth factor (PIGF) 
(Clark and Smith, 2000; Finkelman et al., 1990). Dentin matrix therefore 
contains a cocktail of bioactive molecules with potent cell signaling 
properties, which may be released into the pulp environment during tissue 
injury (Clark and Smith, 2000). While the sequestration of growth factors 
within dentin matrix (Clark and Smith, 2000) provides one possible pool of 
these cell-signaling molecules in the injury situation, fibroblasts and other 
pulp cells may be other sources (Hung et al., 2007; Sloan et al., 2000). Both 
the physiological cell populations of the pulp and the inflammatory cells, 
which locally infiltrate the tissue at sites of injury, also express a number of 
growth factors and may contribute to the overall tissue response (Sloan et 
al., 2000). VEGF, FGF-2, PDGF, TGF-β, and hepatocyte growth factor 
(HGF) are among the growth factors isolated in human pulp tissue 
(Derringer et al., 2004; Hung et al., 2007; Dale et al., 2002). Although 
these sources of growth factors may not become “ fossilized ” in the same 
way as those deriving from the dentin matrix because of the greater turnover 
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in the extracellular matrix of the pulp soft tissue, they will nevertheless 
contribute to the more immediate cellular responses (Sloan et al., 2000). 
Vascular Endothelial Growth Factor (VEGF) 
VEGF is a key regulatory factor in the control of vascular permeability and 
angiogenesis (Ferrara et al., 2002). The ability of VEGF to enhance vascular 
permeability is estimated to be 50,000 times higher than histamine (Ferrara 
et al., 2003). Vascular endothelial growth factor is originally a basic 45-kDa 
heparin-binding glycoprotein. VEGF proteins may become available for the 
endothelial cells (ECs) by at least two different mechanisms: either by 
alternative splicing (originating diffused proteins) or by protease activation 
and longer isoform cleavage (Ferrara et al., 2002). The VEGF family 
includes six known members: VEGF-A, B, C, D, E and Platelet derived 
growth factor (PDGF), along with two growth factor receptors (VEGFR-1 
and VEGFR-2) expressed on the vascular endothelial cell surfaces (Ferrara 
et al., 2003). It has been hypothesized that an increase of VEGF expression 
by the odontoblasts during the bacterial challenge in deep caries might 
contribute to vascular changes in the pulp (Botero et al., 2006). 
Fibroblast Growth factor (FGF) 
FGF is a heparin-binding protein. Fibroblast growth factor was found in 
pituitary extracts by Armelin in 1973 (Armelin et al., 1973) and then was 
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also found in a cow brain extract by Gospodarowicz in 1974 and tested in a 
bioassay which caused fibroblasts to proliferate (first published report in 
1974) (Gospadarowicz et al.,1974). The FGF family consists of nine 
structurally related polypeptides: two prototypes, acidic FGF (FGF-1) (Jaye 
et al., 1986) and basic FGF-2  (FGF-2) (Abraham et al., 1986 a), and seven 
additional members, FGF-3 (Dickson et al., 1984), FGF-4 (Sakamoto et al., 
1986), FGF-5 (Zhan et al., 1988), FGF-6 (Marics et al., 1989), FGF-7 
(Rubin et al., 1989), FGF-8 (Tanaka et al., 1992), and FGF-9 (Miyamoto et 
al., 1993). FGF-2 functions by receptor binding (Ornitz, 2000).  The family 
of FGF receptors includes four members: FGFR1, FGFR2, FGFR3, and 
FGFR4  (Lee et al., 1989; Dionne et al., 1990; Keegan et al., 1991; 
Partanen et al., 1991).  
FGFs are considered multifunctional proteins with a wide variety of effects. 
They are most commonly mitogens but also have regulatory, morphological, 
and endocrine effects. They have been alternately referred to as "pluripotent" 
growth factors and as "promiscuous" growth factors due to their multiple 
actions on multiple cell types (Arese et al., 1999; Vlodavsky et al., 1990). 
Promiscuous refers to the biochemical and pharmacological concept of how 
a variety of molecules can bind to and elicit a response from single receptor. 
In the case of FGF, four receptor subtypes can be activated by more than 
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twenty different FGF ligands. Thus, the functions of FGFs in developmental 
processes include mesoderm induction, antero-posterior patterning, limb 
development, neural induction and neural development (Green et al., 1996) 
and in mature tissues/systems angiogenesis, keratinocyte organization, and 
wound healing processes. 
FGF-1 and FGF-2 are among the fibroblast growth factor most extensively 
studied and have been shown to induce angiogenesis (Baffour et al., 1992). 
During cell injury and repair FGF-2 is involved in repair and tissue 
regeneration (Detillieux et al., 2004). As this process requires angiogenesis, 
FGF-2 has a vital regenerative function in these events. Vessels generated by 
VEGF tend to be “capillary like and leaky” but those produced by FGF-2 
appear to be more mature (Abo-Auda and Benza, 2003). FGF-2 affects 
smooth muscle cells, fibroblasts, and ECs (Slavin, 1995). The ECs are 
stimulated to produce plasminogen activators and matrix metalloproteinases 
causing extracellular breakdown and vascular remodeling. In animal studies, 
increased EC proliferation, increased collateral vessel density, higher 
perfusion pressure and improved regional blood flow have been noted, 
showing the ability of FGF-2 to induce angiogenesis (Baffour et al., 1992). 
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FGF-2 in the Dental Pulp 
The literature pertaining to this specific angiogenic growth factor (FGF-2) 
has shown its presence in pulp tissue and its potentiating and synergistic 
effects on other major angiogenic inducers (VEGF and TGF-β)  (Derringer 
et al., 2004). There are, however, no studies evaluating their presence during 
inflammation in pulp tissue. Inflamed pulp tissues enhance the expression of 
inflammatory mediators. Chu et al., 2004 reported that pro-inflammatory 
cytokines can induce VEGF mRNA gene expression in human pulp, which 
may partially contribute to destruction of pulpal tissues through the 
expansion of the vascular network coincident to progression of 
inflammation.  
Further studies are needed to characterize the biological actions of FGF-2 in 
human inflamed pulp tissue. Elucidation of the biological roles of FGF-2 
may provide information useful in the generation of an agent for the 
treatment of injury of the dentin/pulp complex. This could be utilized for 
future research in order to modulate growth factor expression, design 
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1. Introduction 
 
The formation of new blood vessels is a complex, multistage process closely 
regulated by molecules that induce or inhibit the development of new blood 
vessels. The formation of new blood vessels from pre-existing 
microvasculature (angiogenesis), occurs during tissue repair (Hertig, 1935) 
embryonic development, chronic inflammation and tumor growth. It is a 
complex process, which includes: extracellular matrix remodeling, release of 
proteolytic enzymes, endothelial cell migration, proliferation, capillary 
differentiation and the formation of anastomosis (Folkman et al., 1992). 
This process is regulated by the interplay of numerous cytokines and growth 
factors (Booth et al., 1998). 
The intensity and duration of tooth injury following dental caries or trauma 
determines the nature of the pulpal response. Under pathological conditions, 
angiogenesis is a key step in the healing sequence of the dental pulp with 
hard tissue formation. Injured pulp cells secrete angiogenic growth factors to 
stimulate angiogenesis, which precede the reparative dentin formation (Hung 
et al., 2008). Among the factors released after injury, FGF-2 is known to 
stimulate angiogenesis in vivo (Gerwins et al., 2000) and may act as a 
mitogen for pulp progenitor cells (Nugent et al., 2000). It is well established 
that injured endothelial cells release signaling molecules (FGFs) which are 
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involved in the initiation of the inflammatory reaction and the healing 
process (Martin, 1997) and seem to be involved in the recruitment of 
odontoblast-like cells at the injury site (Mathieu et al., 2005). FGF-2 plays a 
role in the initial inflammation during wound repair in vivo earlier that in the 
absence of FGF-2 (Murakami et al., 1999), and also participates in the 
subsequent tissue healing. Furthermore, an in vitro study demonstrated that 
FGF-2 up-regulated (increased) early neutrophil adhesive interaction with 
fibroblasts and later down-regulated (decreased) it (Zhang et al., 2001). 
The secretion of FGF-2 in healthy and mechanically injured pulps has been 
shown (Derringer et al., 2004; Hung et al., 2007). However, the expression 
of FGF-2 in human inflamed pulp tissue has never been demonstrated. Here 
we present the results of the assessment and quantification of FGF-2 
expression in carious dental pulp as compared to non-carious dental pulp. 
We believe that these results could provide an insight for understanding the 
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2. MATERIALS AND METHODS 
 
A total of 60 teeth (30 carious and 30 non-carious) were obtained from 30 
healthy patients (18-55 years old) scheduled for multiple extractions in the 
Department of Oral Surgery at the University of Michigan, School of 
Dentistry, Ann Arbor, with signed patient’s consent and University’s 
institutional review board (IRB) approval. Both decayed and non-decayed 
teeth were obtained from the same patient source (matched pairs). 
Any history of pain was recorded and vitality evaluated by cold test if pulpal 
diagnosis needed to be confirmed (Hygienic, Inc., Akron, OH). Teeth with 
necrotic pulps and/or periapical pathology or an open apex were not 
included. After extraction, the teeth were immediately placed into sterile 
Transport Medium i.e. high glucose DMEM (Sigma Chemical Co.) 
supplemented with L-glutamine (Gibco), penicillin, streptomycin (Gibco) 
and Amphotericin B (Sigma), on ice. 
After total sample collection, teeth within the carious category were 
separated and grouped as shallow caries (15) (Fig.1) or deep caries (15) (Fig. 
2) based on the depth of decay and its proximity to the pulp chamber.  
Assignment to these groups was made during the vertical sectioning of the 
teeth. Teeth with decay in contact with pulp tissue or within 2 mm of the 
pulp chamber were  
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categorized as deep decay. Teeth with more than 2 mm of sound dentin 
separating the leading edge of the carious lesion from pulp tissue were 
categorized as shallow decay. 
 
                                           
 
Figure 1. A sectioned tooth with the 'Shallow Decay' showing sound dentin 
separating the carious lesion from the pulp chamber. 
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Figure 2. A tooth sectioned with 'Deep Decay' showing the carious lesion in 
contact with the pulp. 
 
PREPARATION OF SPECIMENS 
 
The tooth surface was disinfected using a sterile gauze swab soaked in 70% 
ethanol. Tissue and deposits adhering to the outside of the tooth was 
removed with a sterile curette (Miltex 7-540 / G11-12). 
Each tooth was affixed to a wooden block (3 cm x 3 cm x 1.5 cm) with  
Super Glue (Elmers Products, Columbus, OH) (Fig. 3). These blocks were 
then mounted on an Isomet Low Speed circular saw (Model 650, South Bay 
Technology, Inc., San Clemente, CA) (Fig. 3). The teeth were sectioned 
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vertically (Fig. 4) with a lapidary blade 303 Series (MK-303 Professional, 
MK Diamond Products Inc., Calais, ME) while spraying sterile phosphate 
buffered saline (PBS-1X; Gibco) as a coolant. The saw was sterilized and 
washed with 70% ethanol and sterile PBS before sectioning of the teeth. 
After each tooth was sectioned the pulp was removed intact using sterile 
blunt instruments. The harvested pulp was then vertically cut into halves. 
Each half was placed in a labeled eppendorf tube. Half of the tubes 
contained lysis buffer for protein (NP-40 Reagent/ eBioscience). The rest of 
the tubes contained RNA lysis buffer (Trizol Reagent/ Invitrogen). All 
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Figure 3. Diamond Wheel Saw Model 650 (Southbay Technologies, San 
Clemente, California) with a tooth glued to a wooden mounting in the 
cutting jig. Sectioning was carried out in a fume chemical hood under 
aseptic conditions. 
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ELISA 
The preparation of protein lysate from the first set specimens stored in 
buffered lysate solution was performed following standard protocols 
(Appendix, Section B). Prior to FGF-2 protein analysis, total protein 
concentration from each sample was standardized to 200 µg/ml. Enzyme 
linked immunosorbent assay (ELISA) (Quantikine Human Kit; R & D 
Systems, Minneapolis, MN, USA) was used to measure the concentration of 
FGF-2 in the specimens stored in. A standardized solution of FGF-2 was 
made with 2 ml of calibrator diluent RD5-14 (R&D Systems Inc., 
Minneapolis, MN).  100µl of assay diluent (RD1-43) was added to each well 
of a 96 well plate followed by 100 µl of assay diluent. This was incubated 
for 2 hours at room temperature. The lysis was then stopped adding 50 µl of 
stop solution (R&D Systems Inc., Minneapolis, MN). The optical density of 
the samples was measured in a spectrophotometer at a wavelength of 450 
nm (DU-20 Beckam, Fullerton, CA, USA) (Appendix, Section C).  
 
RT-PCR 
RNA extraction was performed on the second series of samples according to 
Tryzol standard protocol (Appendix, Section D). For FGF-2 mRNA 
evaluation a reverse transcriptase (RT) reaction for cDNA (Invitrogen) 
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(Apendix, Section E) and a polymerase chain reaction (PCR) (Invitrogen) 
were carried out (Apendix, section F). GAPDH was run as house keeping 
gene and human dental pulp fibroblasts (HDPF) as controls. For semi-
quantitative data analysis the mRNA expression was normalized to GAPDH 
and densitometric analysis by image-J was done. (Appendix, Section G). 
Real-Time PCR 
 Following semi-quantification, Real Time PCR  (Applied BioSystems) was 
carried for quantitative analysis. Reverse Transcriptase  (RT) was preformed 
with 0.5µg total RNA and Oligo (dt) using SuperScripIII (Invitrogen. 
Carlsbad, CA, USA) in a 20µl reaction at 65 °C 5 min, 25 °C 5min,  55 °C 
60 min and 70 °C 15min. Detection of FGF-2 and GAPDH expression level 
were performed with, 1µl of RT product and a 20 µl solution containing 
primers and probe from TaqMan Gene Expression Assays  (GAPDH: S.O 
No: 185831521 and FGF-2: S.O No: 185859498) (Applied Biosystems, 
Foste City, CA, USA) were used. 30µl of PCR reactions were set with 
TaqMan Universal PCR Master Mix (Lot No: MP2182) (Applied 
Biosystems, Foste City, Ca, USA) manufactured by Roche prepared with 15 
µl of master mix, 1.5 µl of primer, 3.5 µl of water and 8 µl of cDNA per 
well. Thermal cycling condition inlcuded 50°C 2 min, 95 °C 10 min 
followed by 40 cycles of 95°C 15 sec and 60 °C 1 min. Cycles were 
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performed using an ABI Prism Sequence Detectiion System 7700 (Applied 
Biosystems). The experiment was performed in triplicates and analyzed by 
standard curve method.  (Appendix, Section H). 
 
Statistical Analysis 
A power analysis was conducted to calculate the minimum sample size 
required to accept the outcome. Based on a t-test with two-sided significance 
level of 0.05, with a sample size of n=32, a 90% power can be detected. 
Statistical analysis was performed on these data to test the proposed 
hypothesis by comparing the FGF-2 mRNA concentration between the 
group with deep caries, using One Way ANOVA or student t-test on Ranks 
with SIGMASTAT 2.0 statistical software (SPSS, Chicago, IL). The level of 
significance was determined at P ≤ 0.05.  For the Real-Time PCR samples 
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3. RESULTS 
 
The FGF-2 protein concentrations found in sound non-decayed teeth was  
from 13 pg/ml up to 928 pg/ml. Within the shallow decay group the lowest 
protein concentration ranged as low as 58 pg/ml and as high as 840 pg/ml. 
Within the deep decay group the lowest protein concentration ranged as low 
as 13 pg/ml and as high as 746 pg/ml. The distribution of the samples in the 
shallow decay group by sex was: 9 females and 6 males, by age: 21-55 y/o 
and  tooth type 15 anterior teeth and 15 posterior teeth.. Optical density and 
FGF-2 protein concentration in pg/ml measured by ELISA. (Table 1).  
The sample distribution in the deep decay group by sex was: 6 females and 
9 males, by age: 25-54 y/o, and tooth type 7 anterior teeth and 23 posterior 
teeth. Optical density and FGF-2 protein concentration in pg/ml measured by 
ELISA.  Table 2. 
Table showing mRNA concentrations from control and decayed teeth prior 
to RT-PCR and Real-Time PCR analysis. Table 3. 
 
FGF-2 Protein Expression. 
 
FGF- 2 protein expression was evaluated by ELISA after standardization to 
200 µg/ml per sample. When comparing FGF-2 expression in shallow and 
deep decayed groups with their non-decay controls no statistical significance 
was found (P<0.942 for shallow decay) and (P<0.642 for deep decay by t-
test) (Figs: 5 and 9 ). In the shallow caries group, FGF-2 expression was up-
regulated (increased) in 9 of 15 samples (60%) (Fig. 6 and 7) and down-
regulated (decreased) in 6 of 15 samples (40%) (Fig. 6 and 8). In the deep 
caries group, FGF-2 expression was up-regulated in 7 of 15 samples (46%)  
(Figs: 10 and 11) and down-regulated in 8 of 15 samples (54%) (Figs: 10 
and 12).  
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A statistical significant difference was noted within those samples in the 
shallow decay group showing up-regulation (P<000.6, t-test) and down-
regulation (P<0.0035 t-test) in FGF-2 expression (Fig. 7 and 8). The same 
was also noted for those samples within the deep decay group showing up-
regulation (P<0.0039 t-test) and down-regulation (P<0.0041 t-test) in FGF-2 
expression (Figs: 11 and 12). A trend of FGF-2 up-regulation was noticed in 
the shallow decay group when analyzing the data of FGF-2 expression from 
the teeth that had up-regulation versus their controls (Fig. 5). 
 
FGF-2 mRNA Expression  
mRNA FGF-2 expression was evaluated by RT-PCR (Fig. 13). For semi-
quantitative data analysis the mRNA expression was normalized to GAPDH 
by densitometric analysis. This analysis showed similar trends of increase or 
decrease of mRNA FGF-2 expression as compared to the expression 
analyzed by ELISA in 10 of 15 samples (67%) for the shallow decay group 
(Fig.14) and in 8 of 15 samples (54%) for the deep decay group (Fig. 15). 
 
Real-Time PCR (qPCR)  
Quantitative Real time mRNA FGF-2 expression did not show a statistically 
significant difference when comparing the non-carious group versus the 
carious groups (shallow and deep decay) (P<0.32). This analysis showed 
similar trends of increase in mRNA FGF-2 expression as analyzed by RT-
PCR in 5 of 15 samples for the shallow decay group (#4 SD, #11 SD, #19 
SD, #20 SD, #23 SD) and in 4 of 15 samples for the deep decay group (#9 
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Samples distribution for the shallow decay group and FGF-2 expression 
analyzed by ELISA 
 
Sample Sex Age Tooth type 
Optical 
density    FGF-2 pg/ml 
      
1.1 Control  F 28 y/o Canine #27 0.9033 331.22 
1.3 SD   Central #25 1.6514 656.48 
2.1 Control F 35 y/o Premolar  #20 1.2475 480.87 
2.3 SD   Canine #6 0.8609 520.78 
3.1 Control M 38 y/o Canine #22 1.6737 666.17 
3.3 SD   Molar #19 1.1534 439.96 
4.1 Control M 53 y/o Molar #30 0.1302 0.00 
4.3 SD   Molar #14 0.4411 130.26 
5.1 Control M 55 y/o Molar #31 0.7158 249.70 
5.3 SD   Molar #14 1.061 399.78 
6.1 Control F 46 y/o Canine #6 0.9859 367.13 
6.3 SD   Central #8 1.4847 584.00 
7.1 Control F 38 yo Premolar #13 0.9899 368.87 
7.3 SD   Canine #22 0.2894 64.30 
8.1 Control F 41 y/o Central #26 1.4312 560.74 
8.3 SD   Central #24 0.8145 292.61 
9.1 Control F 47 y/o Molar #15 2.278 928.91 
9.3 SD   Premolar #28 1.0349 388.43 
10.1 SD F 39 y/o Canine #11 1.0973 415.57 
10.3 SD   Molar #30 1.5067 593.57 
11.1 Control F 36 y/o Canine #27 1.6043 636.00 
11.3 SD   Premolar #28 1.0344 388.22 
12.1 Control M 21 y/o Central #24 0.3209 78.00 
12.3 SD   Premolar #29 0.813 291.96 
13.1 Control F 24 y/o Incisor #7  0.5943 196.87 
13.3 SD   Incisor #8 0.2759 58.43 
14.1 Control M 32 y/o Premolar #29 0.4063 0.0 
14.3 SD   Molar #3 0.6669 154.9 
15.1 Control M 44 y/o Central #26 0.8797 420.9 
15.3 SD   Premolar #4 1.215 840.0 
 
Table 1. Sample distribution in the shallow decay group by sex, age, and 
tooth type. Optical density and FGF-2 protein concentration in pg/ml 





   






















Figure 5. FGF-2 protein expression showing the general trend and range of 
expression for the shallow decay group. (P<0.942) (t-test). 
 
           
 
Figure 6. Depicting percentage of samples showing FGF-2 expression up-
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 Figure 7. Samples within shallow decay group showing up-regulation of 
FGF-2 protein expression. A statistical significant difference was present 
between each control and decayed sample (P<000.6) (t-test). C: Non-
decayed tooth. SD:shallow decay tooth. 
 
Figure 8. Samples within shallow decay group showing down-regulation of FGF-2 
protein expression. A statistical significant difference was present between each 
control and decayed sample (P<0.0035) (t-test). C: Non-decayed tooth.  
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Samples distribution for the deep decay group and FGF-2 expression 
analyzed by ELISA 
 
Sample Sex Age Tooth type 
Optical 
Dens pg/ml 
      
1.1 Control F 54 y/o Canine #11 0.1724 13.43 
1.3 DD   Molar #2 0.5767 189.22 
2.1 Control F 43 y/o Incisor #26 0.5242 166.39 
2.3 DD   Premolar #29 0.2499 47.13 
3.1 Control F 42 y/o Premolar #21 0.8655 314.78 
3.3 DD   Premolar #5 0.1762 15.09 
4.1 Control F 48 y/o Premolar #13 0.9816 365.26 
4.3 DD   Molar #3 0.7789 277.13 
5.1 Control M 38 y/o Incisor #9 0.2711 56.35 
5.3 DD   Premolar #4 0.3373 85.13 
6.1 Control M 29 y/o Premolar #21 0.505 158.04 
6.3 DD   Molar #18 0.0775 0.00 
7.1 Control M 27 y/o Premolar #29 0.996 371.52 
7.3 DD   Molar #30 1.8574 746.04 
8.1 Control M 44 y/o Premolar #12 0.3298 81.87 
8.3 DD   Molar #14 0.0946 0.00 
9.1 Control M 25 y/o Molar #19 0.3618 95.78 
9.3 DD   Canine #6 0.1191 0.00 
10.1 Control F 36 y/o Premolar #21 1.5889 629.30 
10.3 DD   Incisor #7 0.9551 353.74 
11.1 Control M  53 y/o Molar #18 0.2166 32.65 
11.3 DD   Molar #19 0.9225 339.57 
12.1 Control F 39 y/o Canine #11 0.3062 71.61 
12.3 DD   Molar #30 0.7076 246.13 
13.1 Control M 34 y/o Premolar #4 0.4636 140.04 
13.3 DD   Canine #6 0.4044 114.30 
14.1 Control M 37 y/o Molar #18 0.2716 56.57 
14.3 DD   Molar #3 0.5582 181.17 
15.1 Control M 30 y/o Molar #19 0.2904 64.74 
15.3 DD   Premolar #4 0.719 251.09 
 
Table 2. Sample distribution in the deep decay group by sex, age, and tooth 





   



















Figure 9. FGF-2 protein expression levels showing the general trend and 
range of expression for the deep decay group. (P<0.642) (t-test). 
 
                    
               
Figure 10. Depicting percentage of sample showing FGF-2 expression being 
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Figure 11. Samples within deep decay group showing up-regulation of FGF-2 
protein expression. A statistical significant difference was present between each 





Figure 12. Samples within deep decay group showing down-regulation of FGF-2 
protein expression. A statistical significant difference was present between each 
control and decayed sample (P<0.0041) (t-test). C: Non-decayed tooth. DD: deep 
decay tooth. 
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mRNA Concentrations 
                    
 Control Decay 
Patient 1 0.3420 µg/ml 1.0703  µg/ml 
Patient 2 0.5990  µg/ml 0.4984  µg/ml 
Patient 3 1.0687  µg/ml 0.5313  µg/ml 
Patient 4 0.2439  µg/ml 0.4162  µg/ml 
Patient 5 0.4783  µg/ml 0.7769  µg/ml 
Patient 6 1.0582  µg/ml 0.4419  µg/ml 
Patient 7 0.2425  µg/ml 0.4542  µg/ml 
Patient 8 0.4852  µg/ml 0.5336  µg/ml 
Patient 9 0.4029  µg/ml 0.5661  µg/ml 
Patient 10 0.5843  µg/ml 0.5460  µg/ml 
Patient 11 0.4495  µg/ml 3.0871  µg/ml 
Patient 12 0.9951  µg/ml 1.2436  µg/ml 
Patient 13 2.2134  µg/ml 1.0184  µg/ml 
Patient 14 2.5854  µg/ml 1.1539  µg/ml 
Patient 15 1.3756  µg/ml 0.9344  µg/ml 
Patient 16 1.6111  µg/ml 0.8942  µg/ml 
Patient 17 1.5854  µg/ml 2.0730  µg/ml 
Patient 18 1.8864  µg/ml 1.0944  µg/ml 
Patient 19 0.6588  µg/ml 4.0554  µg/ml 
Patient 20 1.1702  µg/ml 3.0542  µg/ml 
Patient 21 0.7277  µg/ml 1.4903  µg/ml 
Patient 22 2.6693  µg/ml 1.6942  µg/ml 
Patient 23 0.5278  µg/ml 1.6650  µg/ml 
Patient 24 2.1949  µg/ml 0.5964  µg/ml 
Patient 25 1.4859  µg/ml 1.3918  µg/ml 
Patient 26 1.8708  µg/ml 2.3307  µg/ml 
Patient 27 1.6435  µg/ml 2.5361  µg/ml 
Patient 28 1.3854  µg/ml 1.0382  µg/ml 
Patient 29 2.5787  µg/ml 2.4038  µg/ml 
Patient 30 1.8171  µg/ml 1.3555  µg/ml 
 
Table 3. Table showing mRNA concentration from control and decayed 
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mRNA FGF-2  Expression analyzed by RT-PCR. 
 
A.   Sample #10 /  Shallow Decay group 
           
Densitometry/FGF-2: 1283 (C)  3276 (SD)   
Dens itometry/GAPDH: 1876 (C) 973 (SD)             
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B. Sample #12 / Deep Decay group            
     
 
Densitometry/FGF-2: 785 (C)   3411 (DD)   
Dens itometry/GAPDH: 1963 (C) 1061 (DD)            
 
 
Figure 13. Selected samples from shallow decay (SD) (sample #10, A), and 
deep decay groups (DD) (sample #12, B) showing up-regulated FGF-2 
mRNA and protein expression. mRNA FGF-2 expression as analyzed by 
RT-PCR. GAPDH was run as house keeping gene and Human dental pulp 

























   






Figure 14. FGF-2 expression in the shallow decay group showing up-
regulation and down-regulation in the control vs the shallow decay group. 
The optical density of each amplified band was calculated using the Image J 
software Program (1.32 j) and then numerically expressed as the relative 
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Figure 15. FGF-2 expression in the deep decay group showing up-regulation 
and down-regulation in the non-decay vs the deep decay teeth. The optical 
density of each amplified band was calculated using the Image J software 
Program (1.32 j) and then numerically expressed as the relative density and 
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Figure 16. Graph representing the relative expression by means of Real-
Time PCR. Quantitative Real time mRNA FGF-2 expression did not show a 
statistically significant difference when comparing the non-carious group 
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Summary of the Results 
The analysis of protein expression evaluated by ELISA showed up-
regulation in the shallow caries group in 9 of 15 samples (60%) and down-
regulated in 6 of 15 samples (40%). In the deep caries group FGF-2 
expression was up-regulated in 7 of 15 samples (46%) and down-regulated 
in 8 of 15 samples (54%). No statistical significant difference was found 
when comparing FGF-2 expression in all shallow or deep decayed samples 
to non-decayed samples. Densitometric analysis of RT-PCR showed similar 
trends of increase or decrease of FGF-2 expression as analyzed by ELISA in 
10 of 15 (67%) in the shallow decay group and 8 of 15 (54%) in the deep 
decay group. Quantitative analysis measured by Real Time PCR did not 
show a statistically significant difference when comparing FGF-2 expression 
in the non-carious versus the carious group. Age, sex and tooth type did not 
appear to be determinant factors in the up-regulation or down-regulation of 
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4. DISCUSSION 
The dental pulp has an inherent regenerative potential. Angiogenesis is 
critical in healing and is regulated by the interplay of numerous growth 
factors. FGF-2 is one of these growth factors and plays a significant role in 
the revascularization of damaged or traumatized tissue (Gerwins et al., 
2000). This study demonstrates that human pulp tissue contains fibroblast 
FGF-2 both in health and during inflammation. 
A number of studies have reported the release of FGF-2 from normal 
(Derringer et al., 2004, Shimabukuro et al., 2005, Hung et al., 2006, and 
Hung et al., 2007) and injured human pulp tissue (Hung et al., in 2007). In 
the last mentioned study fibroblasts were cultured in vitro and mechanically 
injured with scalpels. The production of this growth factor during 
inflammation has not been investigated.   
In the current study FGF-2 concentration was measured in sound and 
decayed teeth by ELISA. Up-regulation of FGF-2 was more common in the 
shallow than in the deep decay group although the difference was not 
statistically significant. The same pattern was found when mRNA levels for 
FGF-2 were evaluated by RT-PCR. The hypothesis that pulp tissue removed 
from teeth with carious lesions would show an increase in FGF-2 expression 
over tissue from intact teeth is thus not supported. This is despite the fact 
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that FGF-2 is present in dentin and would be released during the breakdown 
due to caries (Goldberg and Smith, 2004). 
The failure to support the hypothesis could be due to a number of factors. 
The literature supports how the presence of bacteria in carious pulp exposure 
may modify growth factor release and cell activity (Rutherford et al., 2000; 
Rutherford et al., 2001). It has been shown how bacteria that invade the 
dentin can diffuse through dentinal tubules and become involved in the 
pathogenesis of pulpitis (Love and Jenkins, 2002). Depth of bacterial 
invasion may depend, at least in part, upon tubule diameter, since this 
determines the rate of solute diffusion (Pashley, 1992). Sclerotic or 
obliterated tubules will physically impede bacterial invasion and can result 
in regional differences in bacterial invasion of dentin. Limiting nutritional 
supply may influence the depth of bacterial penetration. This may account 
for the higher numbers of cariogenic bacteria within superficial dentin 
(Edwardsson, 1987), where the presence of fermentable carbohydrates and 
oxygen from the oral cavity is likely to be higher than in deeper dentin. 
Collected decayed teeth in our study were grouped into shallow or deep 
decay based on the depth of decay and its proximity to the pulp chamber. 
This was determined by clinical observation after vertical sectioning of the 
teeth. Histologic evaluation to determine the exact depth of bacterial 
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invasion and type of cariogenic microflora present in our samples was not 
determined. This is a limitation of our study. It would have been relevant to 
measure the FGF-2 expression within these sections of decayed dentin to 
determine if any correlation exists between depth of bacterial invasion and 
growth factor expression. Perhaps this could have provided clarification for 
the trend of up-regulation present within the shallow decay group and not 
the deep decay group.  
It has been shown how the distribution of growth factors between the soluble 
and insoluble tissue compartments of the dentin matrix may reflect the 
manner in which they become sequestered within the tissue and will also 
determine their potential release characteristics (Clarks and Smith, 2000). 
Transforming growth factors (TGFs) are reportedly associated with several 
molecules in dentin matrix (Smith et al., 1998) and their distribution 
between the soluble and insoluble tissue compartments would determine the 
sites of growth-factor localization. The observed distribution of angiogenic 
growth factors in dentin presumably reflects their association with various 
extracellular matrix molecules. This association may influence not only their 
distribution but also their biological effects, as interactions with extracellular 
matrix molecules provide one level of regulation of growth-factor activity 
(Gospodarowicz et al., 1990; Kim et al., 1998). The higher concentrations 
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of most of these growth factors in the soluble tissue compartment will allow 
more ready release during carious or other injuries. Both growth factor 
distribution and concentration between these dentin matrix compartments 
are factors that may have influenced the difference in FGF-2 expression 
within our samples. 
Before actual caries exposure, the dental pulp beneath shallow caries is 
capable of mounting innate immune responses to slow down the caries 
invasion. The ability of the odontoblast to respond to caries or injury and up-
regulate its secretory activity leading to deposition of reactionary dentin is 
well-established (Smith et al., 1994). The process of reactionary 
dentinogenesis involves up-regulation of odontoblast activity, often in 
quiescent cells at the stage of physiological secondary dentinogenesis, in 
response to the injury stimulus (Smith et al., 1995). The nature of the 
signaling process from this stimulus may be rather variable and has been 
hypothesized to result from the release of growth factors and other bioactive 
molecules from the dentin matrix during injury (Smith et al., 1995). 
Consequently, the up-regulatory signaling may be rather non-physiological 
and lead to compositional differences in matrix secretion during 
dentinogenesis. This may have played a role in the signaling for the up-
regulation of secretory activity seen in the FGF-2 expression in the shallow 
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decay group. Thus, allowing a trend of up-regulation within the shallow 
decay teeth. 
Morphological changes in odontoblast beneath caries lesions have been 
reported (Bjørndal and Darvann, 1998), and in very active or deep lesions, 
tertiary dentinogenic processes may be absent altogether (Bjørndal and 
Darvann, 1998). Cell signaling in our samples with more severe pulp injuries 
may have down-regulated the secretory activity showing a decrease in FGF-
2 expression within the deep decay group. Furthermore, these samples with 
deep decay may have witnessed a more chronic stage of inflammation with 
possible partial necrosis, which could have decreased the FGF-2 secretion 
within the pulp.  
Wound healing is a complex process involving inflammation. FGF-2 is 
considered to participate in an early stage of the wound-healing process 
(Gibran et al., 1994; Yu et al., 1994). It has been reported that during the 
early stages of wound healing FGF-2 accelerates this process by increasing 
inflammatory cell infiltration (polymorphonuclear leukocyte, monocyte, and 
macrophage) into the wound (Tanaka et al., 1996). This may provide an 
explanation for the trend of FGF-2 up-regulation present in the shallow 
decay group, which was probably undergoing more of an acute 
inflammatory phase, thus, an increase in FGF-2 participation. If this 
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hypothesis is true, FGF-2 down-regulation would be expected in those teeth 
within the deep decay group which were probably undergoing a more 
chronic stage of inflammation, as noted within our results. 
A particular observation to be made is that FGF-2 expression in the coronal 
pulp could differ from the radicular pulp. The coronal pulp is larger and 
contains many more elements than radicular pulp. Both pulp areas contain 
the same elements, although the cells, fibers, blood vessels, and nerves are 
more numerous in the coronal pulp (Okihi et al., 1997). The distribution of 
sympathetic fibers is also highest in blood vessels in the pulp horns near the 
odontoblastic region and lowest in the apical region (Avery et al., 1980). 
The cell-rich zone is present in the coronal pulp and has a relatively high 
density of cells. This zone is discernible due to its higher density of 
fibroblast than the pulp proper and is much more prominent in the coronal 
pulp than in the radicular pulp. After each tooth was sectioned the pulp was 
removed and cut into halves. Providing sample analysis from coronal and 
radicular pulp. It would be reasonable to speculate that the cellular 
differences between these two sections could have influenced the expression 
of FGF-2. We hypothesize that a higher concentration of FGF-2 would 
probably be detected coronally than apically.  
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Additionally, the nature of the signaling process may be variable between 
individuals. Although both decayed and non-decayed teeth were obtained 
from the same patient, biological and morphological differences in patients 
can give rise to inter-patient and intra-patient variation in response 
(Derringer et al., 2004). As well as alteration in levels and response to FGF-
2 throughout life (Gao et al., 1996), there is also evidence that different 
individuals may possess different levels of angiogenic growth factors. Large 
variations in levels of VEGF have been reported in periodontal tissues with 
age and inflammatory factors (Booth et al., 1998). Similarly variations in 
levels of FGF-2 in the pulp during inflammation may occur.  
A power analysis was conducted to calculate the minimum sample size 
required to accept the outcome. Based on a t-test with two-sided significance 
level of 0.05, with a sample size of n=32, a 90% power could be detected. A 
total of 30 matched pairs were collected in our study due to the difficulty in 
obtaining a decayed and a non-decayed tooth from the same patient. It would 
be interesting to evaluate the results of FGF-2 expression with a larger 
sample size and determine if any difference in growth factor expression 
would be present. 
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Age, sex and tooth type within our samples were not explanatory variables 
for the up-regulation or down-regulation of FGF-2. Although comparison 
with similar studies would be interesting, there are, however, no studies 
evaluating the expression of FGF-2 in human inflamed pulp tissue to 
compare with our results.  
The hypothesis is worthy of further investigation and the observations stated 
above should be considered. This investigation brings more questions 
regarding FGF-2 expression in the pulps of teeth with carious lesions. Future 
studies demonstrating and quantifying angiogenic growth factor expression 
in pulp tissue should assess the same in the carious dentin of the same 
specimen. Correlation in growth factor expression between dentin and pulp 
could provide further understanding of cell-signaling mechanisms. Studies 
that exploit cell-signaling properties could have potential for the 
development of therapeutic strategies to modulate growth factor expression 
during pulpitis and/or dentinogenesis. 
This study contributes to our understanding of the pathophysiology of the 
dental pulp and the mechanisms responsible for tooth pulp repair. It opens 
another research orientation concerning angiogenic growth factor expression 
and their capabilities for changing the clinical management of disease in the 
dentin-pulp complex. 
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5. CONCLUSIONS: 
 
1. Human pulp tissue contains fibroblast growth factor (FGF-2) both in 
health and during inflammation. 
2. In the shallow caries group FGF-2 expression was up-regulated in 9 of 
15 samples (60%) and down-regulated in 6 of 15 samples (40%).  
3. In the deep caries group FGF-2 expression was up-regulated in 7 of 15 
samples (46%) and down-regulated in 8 of 15 samples (54%). 
4. No statistical significant difference was found when comparing FGF-2 
expression in shallow and deep decayed groups with their non-decay 
controls. 
5. A trend of FGF-2 up-regulation was noticed in the shallow decay 
group when analyzing the data of FGF-2 expression from the teeth 
that had up-regulation versus their controls. 
6. Densitometric analysis of RT-PCR showed similar trends of increase 
or decrease of FGF-2 expression as analyzed by ELISA in 10 of 15 
(67%) in the shallow decay group and 8 of 15 (54%) in the deep decay 
group. 
7. Quantitative analysis measured by Real Time PCR did not show a 
statistically significant difference when comparing FGF-2 expression 
in the non-carious versus the carious group. 
8. Age, sex and tooth type were not related to the expression of FGF-2 
within either control nor carious group. 
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LABORATORY PROTOCOLS 
A. Preparation of Specimens 
 
The tooth surface was disinfected using a sterile gauze swab soaked in 70% 
ethanol. Tissue and deposits adhering to the outside of the tooth was 
removed with a sterile curette (Miltex 7-540 / G11-12). 
Each tooth was affixed to a wooden block (3 cm x 3 cm x 1.5 cm) with 
Super Glue (Elmers Products, Columbus, OH). These blocks were then 
mounted on an Isomet Low Speed circular saw (Model 650, South Bay 
Technology, Inc., San Clemente, CA) (Fig. 3). The teeth were sectioned 
vertically with a lapidary blade 303 Series (MK-303 Professional, MK 
Diamond Products Inc., Calais, ME) while spraying sterile phosphate 
buffered saline (PBS-1X; Gibco) as a coolant. The saw was washed with 
70% ethanol and sterile PBS before sectioning of the teeth. 
After each tooth was sectioned the pulp removed intact using sterile blunt 
instruments. The harvested pulp was then vertically cut into halves. Each 
half was placed in a labeled eppendorf tube. Half of the tubes contained lysis 
buffer for protein (NP-40 Reagent/ Invitrogen). The rest of the tubes 
contained RNA lysis buffer (Trizol Reagent/ Invitrogen). All specimens 
were then stored at -80 ºC. 
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B. Preparation of Protein Lysates (NP-40 Lysis buffer) 
1. Pulp tissue was thawed on ice. 
2. Tissue was crushed (homogenized) with sterile pestles /Time: 20-30 min 
on ice. 
3. Vortex for 20-30 sec every 3-5 min. 
4. Spin 10 min at 13000 rpm, 4 ºC. 
8. Collect the supernatant (protein lysate) and store in -80 ºC. 
9. Reading of protein concentration by Bio-rad Protein (BIO-RAD 
Laboratories, Inc., Hercules, CA) Optical density measured at 595 nm in 
Spectrophotometer (GENios RECAN. Spectra Fluor Plus. M-Code: 
1560063). 
10. Protein concentration was standardized to 200 Ug/ml of total protein 
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C. FGF-2 ELISA Protocol For Cell Culture Supernate Samples (R & D 
Systems Inc, Minneapolis, MN). 
1. FGF-2 Standard Preparation: Reconstitute the FGF-2 Standard with 2 ml 
of the Calibrator Diluent RD5-14. This produces a stock solution of 640 
pg/ml. Allow the standard to sit for 15 mins with gentle agitation prior to 
making diluents. 
2. Standard Dilution Series: Using eppendorfs pipette 500 µl of Calibrator 
Diluent RD5-14 into each tube. Use the stock solution to produce a dilution 
series: (640 pg/ml, 320 pg/ml, 160 pg/ml, 80 pg/ml, 40 pg/ml, 20 pg/ml, 10 
pg/ml). 
3. Assay Procedure:  
a  Remove excess microplate strips from the plate frame, return them to the 
foil pouch containing the desiccant pack, reseal. Make sure to allow for 
triplication of each sample in the wells.  
b. Add 100 µl of Assay Diluent (RD1-43) to each well. 
c. Add 100 µl of Standard or sample to each well. Total protein 
concentration from each sample was previously standardized to 200 µg/ml 
and adjusted with the RD1-43 diluent.  Cover with the adhesive strip 
provided and incubate for 2 hours at RT. Place the plate into the foil pouch 
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and seal it. Record the sample triplication on plate layout sheet provided.  
d. Aspirate each well and wash, repeating the process twice for a total of 
three washes. Wash by filling each well with Wash Buffer (approx 400 µl 
per wash), using a finnpipette (Fisherbrand). Tap the well plate, gently on 
the bench to obtain complete removal of wash buffer, after the last wash. 
Wash buffer remnants will cause dilution of the assay reagents to be used 
next, interfering with the reaction giving erroneous results.  
e. Add 200 µl of FGF-2 Conjugate to each well. Cover with an adhesive 
strip. Incubate for 2 hours at RT and place the plate into the foil pouch.  
f. Repeat the washing as in step d, being careful to wash correctly so as to 
remove the unbound antibody and wash buffer completely.  
g. In a dark room add 200 µl of Substrate Solution (A,100 µl plus B, 100 µl) 
to each well. Incubate for approximately 30 mins at RT.  
h. Add 50 µl of Stop Solution to each well, observing a color change in each 
well. If the color change does not appear uniform gently tap the plate to 
ensure through mixing. 
i. Determine the optical density of each well within 30 mins following step 
h, using a microplate reader set to 450 nm. 
7. Re-calculate the concentration of growth factors in the medium by 
multiplying each sample reading from the microplate reader by a factor of 
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100, to allow for dilution (step 2). The standard preparation must be in pg/ml 
not ng/ml to prevent overflow, as pg/ml concentration is the standard which 
the microplate reader will use to compare to the triplicated samples. 
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D. RNA EXTRACTION 
1. Thawed, passed to eppendorf tubes from -80 ºC on ice (tissue was 
crushed) and keep at room temperature for 5  minutes. 
2. Add chloroform (200 µl). 
3. Shake by hand and keep at room temperature for 2-3 minutes. 
4. Spin at 12.000 xg / 15 min/ at 4 ºC. 
5. Transfer only aqueous phase to a new labeled eppedorf tube. 
6. Add 0.5 ml of Isopropyl alcohol.  
7. Kept at temperature for 10 min. 
8. Spin at 12.000 xg/ 10 min/ 4 ºC. 
9. Remove supernatant and wash pellet w/ 75% ethol in DNase water. 
10. Spin at 7500 xg/ 5 min/ at 4 ºC. 
11. Remove supernatant and re-suspend. 
12. Measure mRNA with 1µl of sample on 99 of water (µg/ml). 
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E. REVERSE TRANSCRIPTASE / First Strand cDNA Synthesis 
 
Sequence of Primers:  
 
FGF-2: Sense: 5’-GCC-GTC-AAG-GCC-CAC-CCT-G-3’ 
      Antisense: 5’-ATG-CGC-AGG-AAG-AAG-CCC-CC-3’ 
 
GAPDH: Sense: 5’ -GAC-CCC-TTC-ATT-GAC-CTC-AAC-T-3’ 
         Antisense: 5’ -CAC-CAC-CTT-CTT-GAT-GTC-ATC-3 
 
1. 1 µl Oligo DT (200-500 mg). Random Primer (50-250 mg). 
2.  (0.5 µg mRNA). 
3. 1 µl / dNTP. 
4. DNase RNase Water up to 9 µl. Asjudted to final volume to 13 µl. 
Mastercycler Gradient (Eppendorf Scientific Inc., New York, USA) 
Steps :     Program (TBRT): 65 C / 5 min 
                                             Hold at 4 ºC. 
                                        4 µl 5X First-Strand Buffer 
                                  1 µl 0.1M DTT 
                                            1 µl RNase OUT 
                                  1 µl SuperScript enzyme 
                                  Total Volume: 20 µl 
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Steps:     Program (TBRT2):  25 ºC / 5 min 
                                                   55 ºC / 60 min 
                                                   70 ºC /15 min 
                                                    Hold at 4 ºC. 
Keep at -20 ºC. Dilute 20 µl in 80 µl (5X dilution) with DNase water prior to 
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1. Add Water-----------------------35.8 + 4 µl 
2. 10x PCR Buffer-----------------5 µl + 1 µl  
3. 50 mM MgCL2------------------2 µl 
4. 10 mM dNTP--------------------1 µl 
5. Sense Primer (25mM)----------1µl 
6. AntiSense Primer------------------1µl 
7. Taq Platinum Polymerse-------0.4 µl (Invitrogen Inc. 500 rxn (5µ/µl). 
Total Volume per tube-----------------50 µl 
     8.cDNA-------------------------------6 µl 
Mastercycler Gradient (Eppendorf Scientific Inc., New York, USA) 
Steps:    Program (ZZCPCR1): 
1. 94 ºC.:  2 min  
2. 94 ºC.:  30 sec 
3. 55 ºC.: 30 sec 
4. 72 ºC.: 30 sec 
5. 72 ºC.: 10 min 
6. 4 ºC.: Hold 
Keep samples at -20 ºC.
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G. DENSITOMETRIC ANALYSIS 
 
 
1. PCR band images from TIFF files were transferred to Image J program 
(software Program 1.32 j). 
 
2. Each band image pixel value was then individually analyzed. Distance 
and angles were measured and density histrograms created. 
 
3. The optical density of each amplified band was calculated and then 
numerically expressed as the relative density and normalized to the house-
keeping gene (GAPDH). 
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H. Real-Time PCR (qPCR)  
 
Sequence of Probes: 
 
GAPDH: Assay # Hs 99999905_m1 
TGGGCGCCTGGTCACCAGGGCTGCT 
 
FGF-2: Assay # Hs 00266645_m1 
GAGCGACCCTCACATCAAGCTACAA 
 
1. RT was preformed with 0.5µg total RNA and Oligo (dt) using 
SuperScripIII (Invitrogen. Carlsbad, California 92008, USA) in a 20µl 
reaction at 65 °C 5 min, 25 °C 5min, 55 °C 60min and 70 °C 15min. 
2. Detection of FGF-2 and GAPDH expression level were performed with, 
1µl of RT product and a 20 µl solution containing primers and probe from 
TaqMan Gene Expression Assays  (GAPDH: S.O No: 185831521 / Plate ID: 
647086 and FGF-2: S.O No: 185859498 /Plate ID: 647086) (Applied 
Biosystems, Foste City, CA, USA) were used.  
3. 30µl of PCR reactions were set with TaqMan Universal PCR Master Mix 
(Part No: 4304437 / Lot No: MP2182) (Applied Biosystems, Foste City, Ca, 
USA) manufactured by Roche.  
Total included: 15 µl of master mix, 1.5 µl of primer, 3.5 µl of water and 8 
µl of cDNA per well. 
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4. Thermal condition: 50°C 2 min, 95 °C 10 min followed by 40 cycles of 
95°C 15 sec and 60 °C 1 min. The experiment was performed in triplicates 
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I. STATISTICAL ANALYSIS 
 
Statistics / t-test Analysis / Shallow Decay Group Vs Control. 
Normality Test: Passed (P = 0.011) 
 
Equal Variance Test: Passed (P = 0.942) 
 
Group Name  N  Missing Mean Std Dev SEM  
Control 15 0 186.153 171.260 41.537  




t = 0.296  with 32 degrees of freedom. (P = 0.769) 
 
95 percent confidence interval for difference of means: -109.739 to 147.115 
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Statistics / t-test Analysis / Deep Decay Group Vs Control 
Normality Test: Passed (P = 0.011) 
 
Equal Variance Test: Passed (P = 0.642) 
 
Group Name  N  Missing Mean Std Dev SEM  
Control 15 0 186.153 171.260 41.537  




t = 0.296  with 32 degrees of freedom. (P = 0.769) 
 
95 percent confidence interval for difference of means: -109.739 to 147.115 
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